scorecardresearchBajaj Healthcare Share Price Live NSE, BSE, Today - Bajaj Healthcare Stock

Bajaj Healthcare

BSE: 539872 | NSE: BAJAJHCARE | ISIN: INE411U01027 | SECTOR: Biotechnology & Drugs

318.20 0.75 (0.24%)

23 Apr 2024, 09:58 (IST)
  • Open

    318.70
  • High

    320.80
  • Low

    316.30
  • Prev Close

    317.45
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    8.78B
  • Volume

    5.93K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    -

Company Description

  • Biotechnology & Drugs
  • BSE

    539872
  • NSE

    BAJAJHCARE
  • ISIN

    INE411U01027

Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. Its segments include Bulk Drugs and Formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. Its APIs include ascorbic acid, CH Base and its derivatives, citicoline sodium, carbamazepine, theobromine, ferrous ascorbate, doxofylline, oxcarbazepine, choline bitartrate and its derivatives, octenidine dihydrochloride, vildagliptin, ticagrelor, diosmin, hesperidin and others. Its FDFs include Cellin 500, Septran DS Tablet, Vitajaj C tables 500mg, Ticajaj 90 tablets, Ecojaj 75mg & 150mg, Deferajaj 400mg & 500mg, Vildajaj 50mg and Vildajaj M 50/500. It also offers Inositol Nicotinate and Magnesium L-Threonate.

Company Officers

  • Sajankumar Bajaj

    Executive Chairman of the Board, Managing Director
  • Amit Rajan

    Chief Technology Officer
  • Apurva Bandivadekar

    Compliance Officer, Company Secretary
  • Anil Jain

    Joint Managing Director, Executive Director
  • Namrata Bajaj

    Whole Time Director
  • Dhananjay Hatle

    Whole Time Director